HEMATOLOGICAL MALIGNANCY
Clinical trials for HEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Natural killer cells boost transplant safety in blood cancer trial
Disease control CompletedThis early-phase trial tested whether giving specially selected donor immune cells (NK cells) soon after a stem cell transplant is safe for people with blood cancers. Seventeen patients received increasing doses of these cells to find the safest level. The goal was to see if this…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated May 17, 2026 05:06 UTC
-
New melphalan combo shows promise in Half-Matched transplants for blood cancer patients
Disease control CompletedThis study tested a new version of the chemotherapy drug melphalan (EVOMELA) combined with fludarabine and total body irradiation before a half-matched (haploidentical) stem cell transplant in 43 adults with blood cancers like multiple myeloma. The goal was to see if this approac…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 15, 2026 11:56 UTC